Despite the role of STAT5 in JAK2-driven MPN promoting a PV phenotype, CALR mutation is unable to induce polycythemia or ligand independence when co-expressed with the EPO receptor [52,56]. The gene discussed is CALR; the disease is myeloproliferative neoplasm.